Epstein Secrets

ions in Algorithms and Computational Robotics, B. Donald, K. Lynch and D. Rus, Eds., A. K. Peters, Natick

esides, G. M., J. Am. Chem. Soc., 1998, 120, 12670-12671. 621. "Rapid Prototyping of Microfluidic Systems in Poly(dimethylsiloxane)", Duffy, D. C., McDonald, J. C., Schueller, O. J. A. and Whitesides, G. M., Anal. Chem., 1998, 70, 4974-4984. 620. "Three-Dimensional Mesoscale Self-Assembly", Huck, W. T.

Micropattemed Surfaces for Control of Cell Shape, Position, and Function", Chen, C. S., Mrksich, M., Huang, S., Whitesides, G. M. and Ingber, D. E., Biotech. Frog, 1999, 14, 356.363. 633. "Fabrication of Glassy Carbon Microstructures by Soft Lithography", Schueller, O. 3. A., Brittain, S. T. and Whites

the HIX ($14.3bn in 2018), Medtech Tax (2.3%), pharma industry tax ($4.1bn in 2018) & Cadillac tax (effective 2020). As for the views by analysts... Biotech (+) — believe sector will outperform largely as pricing risk has diminished (although will remain in pockets) but pipelines/growth remains. Ying’s to

ves & 2-3mm exchange lives would be a 1-2% EBITDA hit on avg). Focus on company-specific stories like EVHC. MCOs (+) — Fischbeck generally +ve under Trump (especially around MA given historical support from GOP) w/ tailwinds from corporate tax & rising rates. ANTM top pick in given valuation & tailwinds

Nov-12 Feb-13 Aug-13 Nov-13 Feb-14 May-14 Aug-14 Nov-14 Feb-15 Nov-15 Feb-16 May-16 Aug-16 <= ol (A) Chart 12: Near multi-year flat call skew on Biotech (IBB) makes long call spreads an attractive option strategy to initiate or replace long positions to lock-in profits from the recent strong rally 55

ntion) may still find that option markets are currently pricing too little of a move. However, as we have recently argued the debate about whether a Trump win would be good or bad for markets coupled with the inability to exactly pinpoint real risks are likely headwinds to a sizeable market shock. 8 Gl